See every side of every news story

Published 4 days ago • loading... • Updated 4 days ago

Novo Nordisk’s Anti-Obesity Food Frenzy May Be Indigested

Summary by El Pais

The obesity market is saturating. That is the message that conveys Novo Nordisk’s decision (Ozempic manufacturer) to insert muscle into the alliance agreed by Pfizer with the US biotechnology company Metsera. The complexity of the agreement and the high price suggest that pharmaceuticals are acquiring a more risk-resistant stomach.

2 Articles

2 Articles

Novo Nordisk’s Anti-Obesity Food Frenzy May Be Indigested

The obesity market is saturating. That is the message that conveys Novo Nordisk’s decision (Ozempic manufacturer) to insert muscle into the alliance agreed by Pfizer with the US biotechnology company Metsera. The complexity of the agreement and the high price suggest that pharmaceuticals are acquiring a more risk-resistant stomach.

4 days ago·Spain

Read Full Article

Pfizer Takes Novo to Court in Battle over Company with Different Weight Loss Drug

Pfizer is on its way to buying a biotech company before Novo Nordisk made a higher offer on Thursday.

4 days ago·Copenhagen, Denmark

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left2Leaning Right0Center0Last Updated4 days agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Politiken broke the news in Copenhagen, Denmark 4 days ago on Friday, October 31, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics